Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells

Epidermal growth factor receptor (EGFR) is estimated to be overexpressed in 60~80% of colorectal cancer (CRC), which is associated with a poor prognosis. Anti-EGFR targeted monoclonal antibodies (cetuximab and panitumumab) have played an important role in the treatment of metastatic CRC. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hallal, Ralph, Lyu, Nana, Wang, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865832/
https://www.ncbi.nlm.nih.gov/pubmed/33499047
http://dx.doi.org/10.3390/molecules26030567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865832/
https://www.ncbi.nlm.nih.gov/pubmed/33499047
http://dx.doi.org/10.3390/molecules26030567

Ejemplares similares